Tanespimycin is a synthetic derivative of the macrocyclic antibiotic geldanamycin that functions as a potent HSP90 inhibitor, investigated for its potential in treating various solid tumors and chronic… Read more
Tanespimycin is a synthetic derivative of the macrocyclic antibiotic geldanamycin that functions as a potent HSP90 inhibitor, investigated for its potential in treating various solid tumors and chronic myelogenous leukemia. This category offers high-quality reference standards for Tanespimycin, including its identified process and degradation impurities, key metabolites, and stable isotope-labelled compounds. Pharmaceutical and medicinal chemistry laboratories require these materials to ensure rigorous analytical testing, impurity profiling, and method validation throughout the drug development lifecycle. By utilizing these precise reference materials, researchers can accurately identify and quantify related substances, supporting quality control protocols and ensuring compliance with regulatory standards for therapeutic compound purity and stability.